| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
0-136 |
Sentence |
denotes |
Rapid, sensitive and specific SARS coronavirus-2 detection: a multi-center comparison between standard qRT-PCR and CRISPR based DETECTR. |
| T2 |
137-490 |
Sentence |
denotes |
Recent advances in CRISPR-based diagnostics suggest that DETECTR, a combination of isothermal reverse transcriptase loop mediated amplification (RT-LAMP) and subsequent Cas12 bystander nuclease activation by amplicon targeting ribonucleoprotein complexes, could be a faster and cheaper alternative to qRT-PCR without sacrificing sensitivity/specificity. |
| T3 |
491-572 |
Sentence |
denotes |
Here we compare DETECTR with qRT-PCR to diagnose COVID-19 on 378 patient samples. |
| T4 |
573-795 |
Sentence |
denotes |
Patient sample dilution assays suggest a higher analytical sensitivity of DETECTR compared to qRT-PCR, however, this was not confirmed in this large patient cohort, were we report 95% reproducibility between the two tests. |
| T5 |
796-959 |
Sentence |
denotes |
These data showed that both techniques are equally sensitive in detecting SARS-CoV-2 providing additional value of DETECTR to the currently used qRT-PCR platforms. |
| T6 |
960-1071 |
Sentence |
denotes |
For DETECTR, different gRNAs can be used simultaneously to obviate negative results due to mutations in N-gene. |
| T7 |
1072-1197 |
Sentence |
denotes |
Lateral flow strips, suitable as a point of care test (POCT), showed a 100% correlation to the high-throughput DETECTR assay. |
| T8 |
1198-1290 |
Sentence |
denotes |
Importantly, DETECTR was 100% specific for SARS-CoV-2 relative to other human coronaviruses. |
| T9 |
1291-1605 |
Sentence |
denotes |
As there is no need for specialized equipment, DETECTR could be rapidly implemented as a complementary technically independent approach to qRT-PCR thereby increasing the testing capacity of medical microbiological laboratories and relieving the existent PCR-platforms for routine non-SARS-CoV-2 diagnostic testing. |
